News from bayer healthcare A wide array of domestic and global news stories; news topics include politics / government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages, as well.

Oct 21, 2013, 10:00 ET

Bayer's CONTOUR® NEXT LINK Cleared For Use With Medtronic's New MiniMed® 530G With Enlite®

Bayer HealthCare today announced that the U.S. Food and Drug Administration (FDA) has cleared its CONTOUR® NEXT LINK blood glucose monitoring...

Oct 16, 2013, 12:39 ET
The honorable Chris Christie, Governor, State of New Jersey joins President of Bayer HealthCare Phil Blake, and  Marijn Dekkers, Chairman, Bayer AG Group, Board of Management at the ribbon cutting ceremony for the grand opening of the new Bayer HealthCare U.S. headquarters in Whippany, N.J.   (PRNewsFoto/Bayer HealthCare)

Bayer HealthCare Celebrates Opening of State-of-the Art U.S. Headquarters in Whippany

 Bayer HealthCare today announced the opening of its new U.S. headquarters on a 94-acre campus in Whippany, New Jersey, within...

Oct 09, 2013, 08:00 ET

MULTIMEDIA ASSETS NOW AVAILABLE: FDA Approves Bayer's New Class of Drug Adempas® (riociguat) tablets to Treat Adults with PAH and Persistent, Recurrent or Inoperable CTEPH

Bayer HealthCare announced today that the United States Food and Drug Administration (FDA) has approved Adempas® (riociguat) tablets for: (i)...

Oct 08, 2013, 18:54 ET

FDA Approves Bayer's New Class of Drug Adempas® (riociguat) tablets to Treat Adults with PAH and Persistent, Recurrent or Inoperable CTEPH

Bayer HealthCare announced today that the United States Food and Drug Administration (FDA) has approved Adempas® (riociguat) tablets for: (i)...

Oct 03, 2013, 08:32 ET

Bayer Introduces Kogenate® FS Antihemophilic Factor (Recombinant) with Vial Adapter at 2013 NHF Meeting

 Bayer HealthCare announced today that the company is introducing Kogenate® FS antihemophilic factor (recombinant) with Vial Adapter. Vial...

Oct 01, 2013, 09:00 ET

Bayer HealthCare Wants You To Vote For Your Favorite "Chatty Cat"!

 The official voting period for Bayer HealthCare Animal Health's Advantage® II for cats Chatty Cat Challenge opens today....

Sep 25, 2013, 08:30 ET

Bayer's Investigational Drug Riociguat Granted FDA Orphan Drug Designation for Treatment of Pulmonary Arterial Hypertension and Chronic Thromboembolic Pulmonary Hypertension

WHIPPANY, N.J., Sept. 25, 2013 /PRNewswire/ -- Bayer HealthCare today announced that the U.S. Food and Drug Administration's (FDA)...

Sep 24, 2013, 10:58 ET

Rosacea Concierge Sets the Bar for Patient Support with Unique Resources

Rosacea Concierge, a one-of-a-kind resource for the estimated 16 million people living with rosacea1, has been launched by Bayer HealthCare. The...

Sep 20, 2013, 09:20 ET

Zusammengefasste Ergebnisse der EINSTEIN-Phase-III-Studien bestätigen Xarelto® von Bayer als effektives Monotherapeutikum bei venösen Thromboembolien

Behandlung und Prävention venöser Blutgerinnsel: - Alle 37 Sekunden stirbt ein Mensch in der westlichen Welt an Blutgerinnseln,...

Sep 20, 2013, 07:40 ET

Xofigo® (radium Ra 223 dichloride) Injection Recommended for Approval in the European Union

 Bayer HealthCare announced today that the the European Committee for Medicinal Products for Human Use (CHMP) recommended Xofigo® (radium...

Sep 17, 2013, 08:30 ET

Bayer to Present Data on Multiple Oncology Compounds at the European Cancer Congress (ECCO-ESMO-ESTRO) 2013

 Bayer HealthCare announced  today that data from the company's oncology portfolio, including Nexavar® (sorafenib)...

Sep 12, 2013, 14:22 ET
Sheryl Crow, One A Day Women's Nutrition Mission grant competition winner in NYC.  (PRNewsFoto/Bayer HealthCare LLC)

One A Day® Women's, Feeding America® and Sheryl Crow Celebrate Heroes on a "Nutrition Mission" to Fight Hunger in Local Communities

Food insecurity is a problem in America, with some low-income families having to choose, at times, between buying food essentials and paying the...

Sep 10, 2013, 08:01 ET

Bayer and the Broad Institute Join Forces to Develop Novel Treatment Options in Cancer Therapy

 Bayer HealthCare has entered into a strategic alliance with the Broad Institute in Cambridge, Massachusetts in the area of oncogenomics and...

Sep 06, 2013, 09:30 ET
Bayer HealthCare Launches "Chatty Cat Challenge" to Find Out What Keeps Cats Healthy and Happy.  (PRNewsFoto/Bayer HealthCare)

Bayer HealthCare Launches "Chatty Cat Challenge" to Find Out What Keeps Cats Healthy and Happy

 Bayer HealthCare Animal Health's Advantage® II for cats today launches the Chatty Cat Challenge, an opportunity for cat owners...

Aug 30, 2013, 02:30 ET

Bayer's Stivarga® (regorafenib) Tablets Approved in Europe

 Bayer HealthCare and Onyx Pharmaceuticals, Inc. (NASDAQ: ONXX) announced today that the European Commission has approved...

Aug 27, 2013, 02:30 ET

Bayer and Onyx Pharmaceuticals Announce FDA Priority Review Designation of Nexavar® (sorafenib) Supplemental New Drug Application for the Treatment of Radioactive Iodine-Refractory Differentiated Thyroid Cancer

Bayer HealthCare and Onyx Pharmaceuticals (NASDAQ: ONXX) today announced that the U.S. Food and Drug Administration (FDA) has granted Priority...

Aug 06, 2013, 15:18 ET

FDA Advisory Committee Unanimously Recommends Approval Of Bayer's Riociguat In Two Pulmonary Hypertension Indications

 Bayer HealthCare today announced that the U.S. Food and Drug Administration's (FDA) Cardiovascular and Renal Drugs Advisory Committee...

Jul 22, 2013, 07:00 ET
"America's Cats: What We Don't Know Can Hurt Them."  Results of the Bayer Veterinary Care Usage Study III: Feline Findings.  (PRNewsFoto/Bayer HealthCare LLC, Animal Health Division)

Bayer-AAFP study reveals half of America's 74 million cats are not receiving regular veterinary care

 A study conducted by Bayer HealthCare, in collaboration with the American Association of Feline Practitioners (AAFP), found...

Jul 17, 2013, 17:01 ET

The New England Journal of Medicine Publishes Results from the Phase III ALSYMPCA Study of Xofigo® (radium Ra 223 dichloride) Injection

 Bayer HealthCare today announced that data from the pivotal Phase III ALSYMPCA (ALpharadin in SYMptomatic Prostate CAncer) trial of...

Jul 09, 2013, 09:42 ET

Bayer Announces 2013 Recipients of Bayer Hemophilia Awards Program

 Bayer HealthCare has announced the 2013 recipients of the Bayer Hemophilia Awards Program (BHAP). This year, the company awarded more than $2...